Recruiting

Observational Study

Sponsor:

Guardant Health, Inc.

Code:

NCT07620535

Conditions

Colo-rectal Cancer

Eligibility Criteria

Sex: All

Age: 45 - 70+

Healthy Volunteers: Accepted

Interventions

Decision Counseling Session

Study Details

Brief summary:

Prospective, observational, minimal-risk study evaluating decision-making, decisional conflict, intention to undergo complete diagnostic evaluation (CDE), and colonoscopy completion after a positive Shield TM blood-based colorectal cancer screening test result.

Conditions

Colo-rectal Cancer

Study ID

NCT07620535

Start date

Aug 11, 2026

Status verified date

Nov, 2026

Completion date

Jun, 2028

Anticipated

Primary completion date

Dec, 2027

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 45 - 70+

Healthy Volunteers: Accepted

Inclusion Criteria:

  • Participant is 45-75 years old at the time of ShieldTM test order.
  • Participant has a valid Shield(+) test result.
  • Participant is willing and able to complete the informed consent process
  • Participant is able to complete the informed consent process and decision counseling session in English

Exclusion Criteria:

  • Participant is already enrolled in another Guardant Health, Inc. clinical study or has received a positive MCD result for a cancer type other than CRC.

Study Design

Enrollment

350 participants

Anticipated

Interventions and Outcome Measures

Arms

SHIELD Positive with Completed Colonoscopy

Patients who are intending to undergo a complete a diagnostic evaluation

Interventions

Decision Counseling Session

During the decision counseling session, JH research staff will review the Complete Diagnostic Evaluation (CDE) infographic and use an online survey to guide the participant through a telephone encounter that involves the identification of patient goals that are likely to affect their decision to have CDE and not to have CDE.

Primary outcome measure

  • CDE Decisional Conflict [ Time Frame: From Enrollment to the end of study at 6 months ]
  • Factors for CDE Decisional Conflict [ Time Frame: From Enrollment to End of Study at 6 months ]
  • Factors for Changes in CDE Decisional Conflict [ Time Frame: From Enrollment to End of Study at 6 months ]

Central Contacts and Locations

Central contacts

Director of Clinical Trial Operations

855-698-8887dcaf@guardanthealth.com

Locations

Jefferson Center

Recruiting

Philadelphia, Pennsylvania, United States, 19114

Contacts

More Information

Sponsor

Guardant Health, Inc.

Last update posted

Nov 16, 2026

Last verified

Nov, 2026

Keywords

  • Colo-rectal Cancer
  • Screening

Trial information was received from ClinicalTrials.gov and was last updated on 2026-11-17. This information was provided to ClinicalTrials.gov by Guardant Health, Inc. on 2026-11-16. Recruitment status is synced daily from ClinicalTrials.gov and may not reflect the sponsor's current status. Confirm during your call.